However, although a number of the previous studies have investigated the role of GPR40 in hepatic steatosis and inflammation [25–27], the findings are controversial and the role of GPR40 in NAFLD associated with T2DM or MetS has not been well established. This evidence concerns the gene FFAR1 and fatty liver disease.